摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-hydroxyphenyl)-6-phenylhexane | 167145-24-6

中文名称
——
中文别名
——
英文名称
1-(2-hydroxyphenyl)-6-phenylhexane
英文别名
2-(6-Phenylhexyl)phenol
1-(2-hydroxyphenyl)-6-phenylhexane化学式
CAS
167145-24-6
化学式
C18H22O
mdl
——
分子量
254.372
InChiKey
DOVUGDRTPWEQSR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(2-hydroxyphenyl)-6-phenylhexanepotassium tert-butylate 作用下, 以 四氢呋喃N,N-二甲基乙酰胺 为溶剂, 反应 0.33h, 生成 3-(N,N-Dimethylamino]-1-[2-(6-phenylhexyl)phenoxy]-2-propanol
    参考文献:
    名称:
    [2-(.OMEGA.-Phenylalkyl)phenoxy]alkylamines: Synthesis and Dual Dopamine2 (D2) and 5-Hydroxytryptamine2 (5-HT2) Receptor Antagonistic Activities.
    摘要:
    一系列[2-(ω-苯基烷基)苯氧基]烷基胺被合成,并在体外检测了它们对5-羟色胺2 (5-HT2)和/或多巴胺2 (D2)受体的拮抗活性。[2-(4-苯基丁基)苯氧基]烷基胺显示出对5-HT2和D2受体的强烈抑制作用。特别是,[2-(4-苯基丁基)苯氧基]甲基哌啶衍生物,10b、10i和10q,表现出了强大的抑制作用。讨论了这一系列化合物的结构-活性关系。
    DOI:
    10.1248/cpb.46.639
  • 作为产物:
    描述:
    苯戊醛 在 palladium on activated charcoal 氢气1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 乙醇乙腈 为溶剂, 反应 8.0h, 生成 1-(2-hydroxyphenyl)-6-phenylhexane
    参考文献:
    名称:
    [2-(.OMEGA.-Phenylalkyl)phenoxy]alkylamines: Synthesis and Dual Dopamine2 (D2) and 5-Hydroxytryptamine2 (5-HT2) Receptor Antagonistic Activities.
    摘要:
    一系列[2-(ω-苯基烷基)苯氧基]烷基胺被合成,并在体外检测了它们对5-羟色胺2 (5-HT2)和/或多巴胺2 (D2)受体的拮抗活性。[2-(4-苯基丁基)苯氧基]烷基胺显示出对5-HT2和D2受体的强烈抑制作用。特别是,[2-(4-苯基丁基)苯氧基]甲基哌啶衍生物,10b、10i和10q,表现出了强大的抑制作用。讨论了这一系列化合物的结构-活性关系。
    DOI:
    10.1248/cpb.46.639
点击查看最新优质反应信息

文献信息

  • 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles
    申请人:Tsubouchi Hidetsugu
    公开号:US20060094767A1
    公开(公告)日:2006-05-04
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R 1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R 2 represents a group —OR 3 or the like, and R 3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R 1 and —(CH 2 ) n R 2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R 41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.
    本发明提供了一种2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物,其通式如下:其中,R1代表氢原子或C1-C6烷基,n代表0到6的整数,R2代表—OR3或类似的基团,R3代表氢原子、C1-C6烷基或类似的基团,或者R1和—(CH2)nR2可以通过相邻的碳原子通过氮原子结合在一起形成一个螺环,其通式为(H):其中,R41为氢、C1-C6烷基或类似的基团。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型酸性快速细菌具有优异的杀菌作用。
  • Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis
    申请人:SANKYO COMPANY LIMITED
    公开号:EP0600717A1
    公开(公告)日:1994-06-08
    Compounds of formula (I): [wherein: R¹ is aryl; R² is hydrogen, alkyl, alkoxy, halogen or cyano; R³ is a group of formula -B-NR⁴R⁵, where R⁴ and R⁵ are independently hydrogen, alkyl or substituted alkyl or R⁴ and R⁵, together with the nitrogen to which they are attached, form a heterocycle, and B is alkylene or a group of formula -CH₂CH(OR⁶ )CH₂-, where R⁶ is hydrogen, alkanoyl, substituted alkanoyl or arylcarbonyl, or a group of formula -D-R⁷, where D is a single bond or alkylene and R⁷ is a heterocycle; and A is alkylene; and pharmaceutically acceptable salts and esters thereof] are useful for the treatment and prevention of circulatory diseases and psychosis.
    式(I)的化合物:[其中:R¹为芳基;R²为氢、烷基、烷氧基、卤素或氰基;R³为式-B-NR⁴R⁵的基团,其中R⁴和R⁵独立地为氢、烷基或取代烷基,或者R⁴和R⁵与它们所连接的氮一起形成杂环,B为烷基或式-CH₂CH(OR⁶)CH₂-的基团,其中R⁶为氢、烷酰基、取代烷酰基或芳基羰基,或式-D-R⁷的基团,其中D为单键或烷基烯丙基,R⁷为杂环;且A为烷基;以及其药学上可接受的盐和酯]可用于治疗和预防循环系统疾病和精神病。
  • Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis
    申请人:SANKYO COMPANY LIMITED
    公开号:EP0844000A1
    公开(公告)日:1998-05-27
    Compounds of formula (I): [wherein: R1 is aryl; R2 is hydrogen, alkyl, alkoxy, halogen or cyano; R3 is a group of formula -B-NR4R5, where R4 and R5 are independently hydrogen, alkyl or substituted alkyl or R4 and R5, together with the nitrogen to which they are attached, form a heterocycle, and B is alkylene or a group of formula -CH2CH(OR6)CH2-, where R6 is hydrogen, alkanoyl, substituted alkanoyl or arylcarbonyl, or a group of formula -D-R7, where D is a single bond or alkylene and R7 is a heterocycle; and A is alkylene; and pharmaceutically acceptable salts and esters thereof] are useful for the treatment and prevention of psychosis.
    式(I)化合物: 其中R1 是芳基;R2 是氢、烷基、烷氧基、卤素或氰基;R3 是式-B-NR4R5 的基团,其中 R4 和 R5 独立地是氢、烷基或取代的烷基,或 R4 和 R5 与它们所连接的氮一起构成杂环,B 是亚烷基或式-CH2CH(OR6)CH2-的基团,其中 R6 是氢、烷酰基、取代的烷酰基或芳羰基,或式-D-R7 的基团,其中 D 是单键或亚烷基,R7 是杂环;和 A 是亚烷基;及其药学上可接受的盐和酯]可用于治疗和预防精神病。
  • 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP1555267A1
    公开(公告)日:2005-07-20
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group -OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and a typical acid-fast bacteria.
    本发明提供了由以下通式代表的 2,3-二氢-6-硝基咪唑并[2,1-b]恶唑化合物: 其中R1代表氢原子或C1-C6烷基,n代表0至6的整数,R2代表基团-OR3或类似基团,R3代表氢原子、C1-C6烷基或类似基团,或者R1和-(CH2)nR2可以通过氮原子与相邻的碳原子相互结合,从而形成通式(H)代表的螺环: 其中 R41 为氢、C1-C6 烷基或类似基团。本化合物对结核分枝杆菌、多重耐药结核分枝杆菌和典型的耐酸细菌有很好的杀菌作用。
  • 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP2570418A2
    公开(公告)日:2013-03-20
    The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group -OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and -(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.
    本发明提供了一种由以下通式表示的 2,3-二氢-6-硝基咪唑并[2,1-b]恶唑化合物: 其中R1代表氢原子或C1-C6烷基,n代表0至6的整数,R2代表基团-OR3或类似基团,R3代表氢原子、C1-C6烷基或类似基团,或者R1和-(CH2)nR2可以通过氮原子与相邻的碳原子相互结合,从而形成通式(H)代表的螺环: 其中 R41 为氢、C1-C6 烷基或类似基团。本化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型耐酸菌有很好的杀菌作用。
查看更多